Gyöngyi Szabó

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

David W. Crabb, Gene Y. Im, Gyöngyi Szabó et al. · Hepatology · 2019 · 888 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

Toni Delorey, Carly G.K. Ziegler, Graham Heimberg et al. · Nature · 2021 · 878 citations · Full text

Life Sciences, Infectious Diseases, Pathology +13

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

Tímea Csák, Michal Ganz, Justin Pespisa et al. · Hepatology · 2011 · 636 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases

Shashi Bala, Jan Petrášek, Shiv Mundkur et al. · Hepatology · 2012 · 626 citations · Full text

Life Sciences, Immunology, Molecular Biology +17